Carrier Screening Market 2020 - Business Size, Share, Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by Forecast to 2024

2019 Research Report on Global Carrier Screening Market is a professional and comprehensive report on the Carrier Screening industry.

#Download Free PDF Sample Brochure of report Global Carrier Screening Market 2019 across with 149 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2687860

Key Players: Illumina (US), Natera (US), Fulgent Genetics (US), Sema4 (US), Invitae (US), and LabCorp (US). The study includes an in-depth competitive analysis of these key players in the market, along with their company profiles, recent developments, and key market strategies.

“Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market.”

The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.

“The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & micro arrays and recommendations for the use of expanded carrier screening.

“Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market.”

The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.

“The expanded carrier screening segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & micro arrays and recommendations for the use of expanded carrier screening.

Get Flat 20% Discount on this Latest Research Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=2687860

“In 2018, the hospitals segment accounted for the largest share of the carrier screening market.”

On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.

“North America to grow at the highest CAGR during the forecast period.”

North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.

In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the carrier screening market.

Download Free Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2687860

In the end, the Global Carrier Screening Market report’s conclusion part notes the estimation

Connect Us for more information at sales@reportsandreports.com or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.